ClinEdge's Partnerships and Upcoming Fall Presentations

ClinEdge's Partnerships and Upcoming Fall Presentations

BOSTON--(BUSINESS WIRE)--ClinEdge--a full-service marketing, patient recruitment, and clinical operations firm—is pleased to announce 2013 fourth quarter plans and developments. ClinEdge is an industry leader in patient recruitment and retention. Included among these announcements is a new partnership with database powerhouse ClinicalConnection as well as an itinerary of upcoming conference presentations.

ClinEdge's effective services are uniquely designed to support cost-efficient recruitment campaigns across all therapeutic areas. During one of the most recent full service recruitment campaigns conducted for a reputable pharmaceutical organization, ClinEdge's team recruited thirty-seven percent of the study's patients in less than two weeks. Positive results are not limited to ClinEdge's pharmaceutical clients; clinical research facilities contracting with ClinEdge have seen an average patient recruitment participant increase of approximately fifty percent during the past nine months.


In addition to successful recruitment results, ClinEdge proudly announces a newly formed alliance with, the most visited, non-government website in the U.S. for clinical trial searches, notifications and patient referrals. More than 250,000 people visit each month. Sponsors and sites working with ClinEdge will now benefit from increased access to ClinicalConnection's proprietary database of over 400,000 members actively seeking clinical trials throughout the world, and greater online exposure for their trials. Sponsors and sites also benefit from in-depth real time tracking through ClinEdge's TrialTracker services; as well as strategic media placement through ClinEdge's AdEdge: Media Buying service.


Corry Knuth, Associate Director of Clinical Operations at ClinEdge will be presenting at the 2013 Site Summit Solutions, October 11th-13th. Corry will lead the session discussing hidden techniques research sites can utilize to identify studies in a competitive environment.

Christian Burns, Director of Clinical Operations at ClinEdge will co-present with a leading CRO at the 2013 CenterWatch and iiBIG Conference, October 16th 18th. The topic covered will be Establishing Preferred Relationships with Sites.

Shortly thereafter, Associate Director of Marketing and Patient Recruitment Erin Phares and Christian Burns at ClinEdge will host a full-day patient recruitment workshop at the MAGI Conference, October 27th-30th in Las Vegas. ClinEdge designed this workshop to provide site and sponsor attendees with novel recruitment strategies, troubleshooting, and in-depth metrics. Additionally, ClinEdge team members will be moderating and presenting numerous sessions throughout the conference.

For further details regarding our exceptional portfolio demonstrating recent success please visit our online portfolio.

About ClinEdge

ClinEdge is a full-service business development, marketing, and patient recruitment firm dedicated to the success of clinical trials. Headquartered in the greater Boston area, the company has cultivated and maintained strong relationships with the world's leading research facilities, pharmaceutical companies and contract research organizations (CROs). ClinEdge represents a network of highly qualified clinical research sites and principal investigators to essential Pharmaceutical/CRO contacts. The company's central services include; business development for effective study placement and comprehensive marketing and patient recruitment services. Visit for more information.


Erin Phares, 857-496-0054 x 520
Associate Director of Marketing and Patient Engagement
[email protected]

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.